Does NIRAPARIB Cause Product dose omission in error? 428 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 428 reports of Product dose omission in error have been filed in association with NIRAPARIB (ZEJULA). This represents 2.0% of all adverse event reports for NIRAPARIB.
428
Reports of Product dose omission in error with NIRAPARIB
2.0%
of all NIRAPARIB reports
6
Deaths
66
Hospitalizations
How Dangerous Is Product dose omission in error From NIRAPARIB?
Of the 428 reports, 6 (1.4%) resulted in death, 66 (15.4%) required hospitalization, and 3 (0.7%) were considered life-threatening.
Is Product dose omission in error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 428 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Product dose omission in error?
DUPILUMAB (7,586)
TOFACITINIB (2,461)
LENALIDOMIDE (618)
PALBOCICLIB (592)
DIROXIMEL (481)
ABALOPARATIDE (457)
RUXOLITINIB (425)
TERIFLUNOMIDE (371)
DIMETHYL (308)
RELUGOLIX (293)
Which NIRAPARIB Alternatives Have Lower Product dose omission in error Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP